Cargando…

Current State of Respiratory Syncytial Virus Disease and Management

Respiratory syncytial virus (RSV) is a major cause of hospitalizations due to pneumonia and bronchiolitis. Substantial morbidity and socioeconomic burden are associated with RSV infection worldwide. Populations with higher susceptibility to developing severe RSV include premature infants, children w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chatterjee, Archana, Mavunda, Kunjana, Krilov, Leonard R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928170/ https://www.ncbi.nlm.nih.gov/pubmed/33660239 http://dx.doi.org/10.1007/s40121-020-00387-2

Ejemplares similares

Respiratory Syncytial Virus (RSV) Update
por: Krilov, Leonard R., et al.
Publicado: (2022)

737. The Prevalence of Diagnosed Chronic Lung Disease in US Infants by Gestational Age: Implications for RSV Policy
por: Ambrose, Christopher S, et al.
Publicado: (2018)

Respiratory syncytial virus hospitalizations in US preterm infants after the 2014 change in immunoprophylaxis guidance by the American Academy of Pediatrics
por: Krilov, Leonard R., et al.
Publicado: (2020)

Current State and Challenges in Developing Respiratory Syncytial Virus Vaccines
por: Biagi, Carlotta, et al.
Publicado: (2020)

Palivizumab Prophylaxis for Respiratory Syncytial Virus: Examining the Evidence Around Value
por: Olchanski, Natalia, et al.
Publicado: (2018)

Reducing Antibiotic Use in Respiratory Syncytial Virus—A Quality Improvement Approach to Antimicrobial Stewardship
por: Quintos-Alagheband, Maria Lyn, et al.
Publicado: (2017)

The 2014–2015 National Impact of the 2014 American Academy of Pediatrics Guidance for Respiratory Syncytial Virus Immunoprophylaxis on Preterm Infants Born in the United States
por: Kong, Amanda M., et al.
Publicado: (2018)

Respiratory Syncytial Virus: Current Progress in Vaccine Development
por: Rudraraju, Rajeev, et al.
Publicado: (2013)

Respiratory syncytial virus: current and emerging treatment options
por: Turner, Tiffany L, et al.
Publicado: (2014)

Partial palivizumab prophylaxis and increased risk of hospitalization due to respiratory syncytial virus in a Medicaid population: a retrospective cohort analysis
por: Krilov, Leonard R, et al.
Publicado: (2014)

Respiratory syncytial virus: diagnosis, prevention and management
por: Barr, Rachael, et al.
Publicado: (2019)

735. Severity and Healthcare Costs of Respiratory Syncytial Virus Hospitalizations in US Preterm Infants Born at 29–34 Weeks Gestation: 2014–2016
por: Goldstein, Mitchell, et al.
Publicado: (2018)

Respiratory Syncytial Virus Infection: Treatments and Clinical Management
por: Malik, Shiza, et al.
Publicado: (2023)

Protein and Peptide Substances in the Treatment of Respiratory Syncytial Infection: Current State
por: Shtro, Anna A., et al.
Publicado: (2022)

Update on respiratory syncytial virus hospitalizations among U.S. preterm and term infants before and after the 2014 American Academy of Pediatrics policy on immunoprophylaxis: 2011-2017
por: Fergie, Jaime, et al.
Publicado: (2020)

RSV Disease: Current Management and the Future of Treatment and Prevention
por: Krilov, Leonard R., et al.
Publicado: (2021)

740. Impact of the 2014 American Academy of Pediatrics Guidance on Respiratory Syncytial Virus Hospitalization Rates for Preterm Infants <29 Weeks Gestational Age at Birth: 2012–2016
por: Goldstein, Mitchell, et al.
Publicado: (2018)

Respiratory syncytial virus: The virus, the disease and the immune response
por: Ogra, Pearay L.
Publicado: (2004)

The Future of Respiratory Syncytial Virus Disease Prevention and Treatment
por: Domachowske, Joseph B., et al.
Publicado: (2021)

Incidence of Respiratory Syncytial Virus Infection in Older Adults: Limitations of Current Data
por: Rozenbaum, Mark H., et al.
Publicado: (2023)

Respiratory syncytial virus is an “opportunistic” killer
por: Caballero, Mauricio T., et al.
Publicado: (2018)

Respiratory Syncytial Virus
por: Fraire, Armando E., et al.
Publicado: (2013)

Respiratory syncytial virus
por: Ruuskanen, Olli, et al.
Publicado: (1993)

Respiratory syncytial virus
por: Munoz, Flor M., et al.
Publicado: (2020)

743. Severity and Costs of Respiratory Syncytial Virus and Bronchiolitis Hospitalization in Commercially Insured Preterm and Term Infants Before and After the 2014 American Academy of Pediatrics Guidance Change on Immunoprophylaxis
por: Krilov, Leonard R, et al.
Publicado: (2018)

Epidemic dynamics of respiratory syncytial virus in current and future climates
por: Baker, Rachel E., et al.
Publicado: (2019)

Current practices for respiratory syncytial virus surveillance across the EU/EEA Member States, 2017
por: Mollers, Madelief, et al.
Publicado: (2019)

Respiratory syncytial virus infection: an innate perspective
por: Johansson, Cecilia
Publicado: (2016)

Role of Respiratory Syncytial Virus in Pediatric Pneumonia
por: Bianchini, Sonia, et al.
Publicado: (2020)

Mucosal Immune Responses to Respiratory Syncytial Virus
por: Barnes, Megan V. C., et al.
Publicado: (2022)

Host Responses to Respiratory Syncytial Virus Infection
por: Agac, Ayse, et al.
Publicado: (2023)

Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials
por: Broadbent, Lindsay, et al.
Publicado: (2015)

Anti-cancer oncolytic activity of respiratory syncytial virus
por: Echchgadda, I, et al.
Publicado: (2009)

Functional Features of the Respiratory Syncytial Virus G Protein
por: Anderson, Larry J., et al.
Publicado: (2021)

RESPIRATORY SYNCYTIAL AND OTHER VIRUSES ASSOCIATED WITH RESPIRATORY DISEASE IN INFANTS
por: Jacobs, J.W., et al.
Publicado: (1971)

Respiratory Syncytial Virus Hospitalizations among U.S. Preterm Infants Compared with Term Infants Before and After the 2014 American Academy of Pediatrics Guidance on Immunoprophylaxis: 2012–2016
por: Goldstein, Mitchell, et al.
Publicado: (2018)

Impact of Respiratory Syncytial Virus: The Nurse’s Perspective
por: Bracht, Marianne, et al.
Publicado: (2012)

Respiratory syncytial virus entry and how to block it
por: Battles, Michael B., et al.
Publicado: (2019)

The road to approved vaccines for respiratory syncytial virus
por: Ruckwardt, Tracy J.
Publicado: (2023)

Respiratory Syncytial Virus Seasonality — United States, 2014–2017
por: Rose, Erica Billig, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3c1ngtk9rh8oah9istrocapouh